Drug Safety Update: montelukast (Singulair) - reminder of the risk of neuropsychiatric reactions

The Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update highlights new and updated advice.
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news